Homologies between SARS-CoV-2 and allergen proteins may direct T cell-mediated heterologous immune responses
Abstract The outbreak of the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a public health emergency. Asthma does not represent a risk factor for COVID-19 in several published cohorts. We hypothesized that the SARS-CoV-2 proteome contains T cell epitopes, which are potentially...
Enregistré dans:
Auteurs principaux: | Kathrin Balz, Abhinav Kaushik, Meng Chen, Franz Cemic, Vanessa Heger, Harald Renz, Kari Nadeau, Chrysanthi Skevaki |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d7ea8bc1a9ad40099bef607fbcee3efe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
par: Bimmi Shrestha, et autres
Publié: (2010) -
Homology between SARS CoV-2 and human proteins
par: Vladimir Khavinson, et autres
Publié: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
par: Andrew Chak-Yiu Lee, et autres
Publié: (2021) -
Nanoparticle–allergen complexes for allergen immunotherapy
par: Di Felice G, et autres
Publié: (2017) -
Editorial: Activation of Innate Immunity by Allergens and Allergenic Sources
par: Fatima Ferreira, et autres
Publié: (2021)